Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professors Mina Fazel, Morten Kringelbach and Mike Browning have been given the title of Professor in the 2021 Recognition of Distinction Exercise at the University of Oxford.

Professors Mina Fazel, Morten Kringelbach and Mike Browning

Mina Fazel, Professor of Child and Adolescent Psychiatry and Clinical Child and Adolescent Psychiatrist in the Department of Children's Psychological Medicine at the Children's Hospital, Oxford University Hospitals NHS Foundation Trust, has been working in the Department of Psychiatry for over 20 years, investigating the needs of the most marginalised and vulnerable adolescents.


'I am delighted and very grateful to now be Professor of Adolescent Psychiatry. I will continue in both my research and clinical work to try and improve the care that we can offer young people at a crucial time in their development. The importance of conducting research into adolescent mental health has never been more evident. Awareness amongst young people and policy makers is helping to demonstrate the need for innovative new research.'

Morten Kringelbach, Professor of Neuroscience, Director of the Centre for Eduaimonia and Human Flourishing and Senior Research Fellow at Linacre College, said:


'In these difficult times, it is a great honour to be able to contribute to the excellent research in Oxford Psychiatry. Working with my wonderful colleagues I hope we will be able to better understand what is needed for human flourishing and how to translate this into more effective treatments.'

Mike Browning, Professor of Computational Psychiatry and Honorary Consultant Psychiatrist, leads the Computational Psychiatry Lab in the Department of Psychiatry.


 'It is an honour to be made a professor in Oxford. Computational techniques have the potential to improve the treatment of patients and I am really excited to be working in this area.'

Professor Belinda Lennox, Head of Department, University of Oxford, said:


'I'd like to wish Mina, Morten and Mike huge congratulations. They each represent the very best in their field of expertise. Their research and the work of the teams they lead not only enhances, but also helps to strengthen the future of psychiatry research, and so it is fitting that they have been recognised with the title of professor.'






Please follow the link below to read the news on the NIHR BRC website.

Similar stories

How Mindfulness May Improve Body Satisfaction and Mood

New research from Emma Osborne, Research Assistant at the Centre for Research on Eating Disorders (CREDO) at the University of Oxford (and PhD Candidate at the University of Bath), and Dr Melissa Atkinson, University of Bath, investigated two ways in which mindfulness might improve body satisfaction and mood.

Review Highlights Risk Factors Associated with Violence in Schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

New Study will Investigate Brain Fog Symptoms in Post-Hospitalised COVID-19 Patients

C-Fog is a collaborative new study led by Oxford University researcher, Dr Maxime Taquet, which will investigate the reasons why brain fog or cognition problems affect patients after COVID-19 infection. With a better understanding of the mechanisms involved it may be possible to understand how to treat brain fog and help many thousands of people worldwide.

A New Experimental Study Investigated the Effects of Atorvastatin on Emotional Processing

Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.

People with Long-COVID After Hospitalisation Face Limited Recovery After One Year

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised patients.

The Effects of Social Media on Public Attention and Attitudes Towards COVID-19 Vaccines in the UK

A new study finds that media coverage of positive vaccine research can have a positive effect on overall social media sentiment, countering vaccine misinformation, but the effects wane over time.